An announcement from Symphony Limited ( (IN:SYMPHONY) ) is now available.
Symphony Limited announced the sale of technology know-how and nine intellectual property rights by its subsidiary, Guangdong Symphony Keruilai Air Coolers Co. Ltd. (GSK), to IMPCO S de R.I.de C.V., Mexico, for approximately USD 5.1 million. This transaction will allow GSK to repay its loan to Symphony Limited, potentially making it debt-free, while IMPCO benefits from acquiring valuable technology for the Mexican market. GSK will retain a substantial portfolio of IPRs for its core markets, supporting future growth and expansion.
More about Symphony Limited
Symphony Limited operates in the air cooling industry, specializing in the development and sale of air coolers and related technologies. The company focuses on innovation and holds a significant portfolio of intellectual property rights, positioning itself as a leader in technological advancements within its market.
YTD Price Performance: -13.15%
Average Trading Volume: 7,781
Current Market Cap: 75.88B INR
Learn more about SYMPHONY stock on TipRanks’ Stock Analysis page.